Something peculiar has happened to the way Britain sleeps. For years, the enemy of rest was obvious and external – a stuffy bedroom, a sagging mattress, the August heatwave that turned every pillow into a hot water bottle. But in 2026, the enemy has moved indoors. It lives behind the eyelids. It speaks in the voice of tomorrow’s deadlines, yesterday’s arguments, and a thousand tasks that refuse to queue politely. Racing thoughts have officially displaced temperature as the nation’s primary sleep disruptor, and the implications extend far beyond a rough night.
A survey of 2,000 UK adults conducted by Dreams in January 2026 found that 37 per cent of respondents now cite a busy mind as the chief reason they lie awake – up from 28 per cent in 2024, when overheating held the top spot. The shift is not merely statistical. It signals a deeper transformation in Britain’s sleep profile, one driven less by physical comfort and more by the relentless cognitive demands of a culture that never quite switches off.
A Nation Running on Empty
The numbers paint a picture of chronic, collective exhaustion. According to NHS Digital data reported by The Mirror in January 2026, hospital recordings of insomnia have nearly doubled in four years, rising from 15,215 in 2021 to 33,138 in 2025 – almost 100 per day. The NHS Business Services Authority reported that 13.4 million hypnotic and anxiolytic items were prescribed in England in 2024/25, with 1.09 million patients receiving at least one prescription for sleep medication, a figure that has risen each year since 2022/23.
The economic toll is staggering. Research from RAND Europe, cited by NHS Employers in February 2026, estimates that sleep deprivation costs the UK economy approximately £50 billion annually and results in over 200,000 lost working days each year. Sleep Action reports that fatigue-related productivity issues cost UK businesses an estimated £1,248 per employee per year, with sleep deprivation contributing to a 70 per cent higher risk of workplace accidents.
“We are essentially running a national experiment in chronic sleep deprivation,” says Dr Lizzie Hill, Senior Lecturer in Sleep Physiology at the University of the West of England and sleep training lecturer for Sleep Action. “The consequences are not abstract – they show up in medical errors, traffic accidents, mental health crises, and a workforce that is structurally exhausted.”
The Brain That Won’t Shut Up
The 2026 Dreams survey reveals a telling inversion. In 2024, the pattern was physical: too hot (37 per cent), stressed (31 per cent). In 2026, the top disruptor is cognitive – racing thoughts at 37 per cent, with stress at 28 per cent and illness at 31 per cent. The over-55s are disproportionately affected, averaging 3.8 nights of disrupted sleep per week, compared to the national average of 3.4.
Dr Michelle Drerup, Director of Education and Behavioural Sleep Medicine at the Cleveland Clinic’s Sleep Disorders Center, identifies a common pattern: “Waking up in the middle of the night with racing or intrusive thoughts is very common and is actually one of the most frequently reported symptoms of chronic insomnia.” She notes that the problem often begins when daytime distractions vanish – the brain shifts from outward attention to inward processing, and physiological arousal does not always switch off with the lights.
The mental health dimension is particularly acute among younger adults. The Dreams survey found that 38 per cent of 18–24s and 25–34s report mental health affecting their sleep, compared to far lower figures among older generations. This demographic is not merely sleeping poorly; they are sleeping anxiously, caught in a feedback loop where poor sleep worsens mental health, which in turn fragments sleep further.
The Science of a New Target
The neuroscience community is taking notice. A study published in Nature Neuroscience in June 2026 identified tryptamine – a compound related to serotonin – as a key molecular signal of sleep pressure. Researchers found that tryptamine levels in cerebrospinal fluid track the homeostatic drive to sleep, rising with wakefulness and activating GPR139 receptors in the hypothalamic preoptic area to promote rest. The discovery opens potential new avenues for pharmacological intervention, though researchers caution that lifestyle and behavioural approaches remain first-line treatments.
Meanwhile, a 7-day sensor-based observational study published in JMIR mHealth and uHealth in June 2026 provided real-world evidence that daytime sunlight exposure of just one additional hour was associated with a 10.67-minute increase in total sleep time the following night and a measurable decrease in light sleep. Conversely, each minute of smartphone use before bedtime was linked to a 0.2-minute increase in sleep onset latency – a modest but cumulative effect that compounds across an evening of scrolling.
Professor Russell Foster, Director of the Sleep and Circadian Neuroscience Institute at the University of Oxford, has long warned against the “quasi-epidemic of worry” surrounding sleep perfection. “Sleep is like your shoe size; one size does not fit all,” he says. “The healthy sleep range is between six and 10 hours. You’ll know if you aren’t getting enough sleep if you don’t feel like you can function optimally the next day.” His advice is deliberately anti-prescriptive: prioritise routine, get outdoor light in the morning, and resist the temptation to treat sleep as a problem to be optimised rather than a biological process to be respected.
The Treatment Gap
Here lies Britain’s most uncomfortable truth about sleep: the treatment infrastructure does not exist to meet demand. A BBC investigation in February 2026 reported that patients at the Oxford Centre for Sleep and Ventilation at Churchill Hospital face 52-week waits for sleep study results. Jordan, a patient from Wantage, told the BBC that his severe fatigue has landed him in A&E, yet he cannot access treatment for at least a year. “It’s really seriously impacting my life,” he said. “I’ve looked into private companies… but that could cost anywhere from £300 to £1,000.”
The bottleneck is not limited to Oxford. NICE guidance on insomnia management, published in 2025, acknowledged that access to Cognitive Behavioural Therapy for Insomnia (CBT-I) is “insufficient and postcode-dependent.” A study published in BMC Primary Care in December 2025 found that only 1.7 per cent of people with insomnia in North Central London had been referred for CBT-I treatment – the NICE-recommended first-line approach. The researchers described this as “concerning, given the negative health, quality of life and economic implications of untreated insomnia.”
Professor Stephany Biello, a sleep scientist at the University of Aberdeen, advocates for a more personalised approach: “People usually think they can recover sleep by having a lie-in on the weekend, but that just makes it harder to get up on Monday. Getting up at the same time really helps, and then I try to get outside and see natural light. Even in winter, there really is enough light to make a difference.”
What Actually Works
The evidence base for effective sleep intervention is robust, if underutilised. CBT-I, which addresses the thoughts and behaviours that perpetuate insomnia, consistently outperforms medication in long-term outcomes. The therapy involves sleep restriction, stimulus control (using the bed only for sleep), cognitive restructuring of unhelpful beliefs, and structured relaxation techniques. The Department of Health and Social Care is currently tendering to make digital CBT-I available nationally through the NHS, a move that could dramatically expand access.
For those navigating the wait, several evidence-based strategies show consistent results. Scheduling “worry time” earlier in the evening – dedicating 15 to 20 minutes to journaling concerns with clear next steps – reduces the brain’s tendency to rehearse problems at bedtime. The 4-7-8 breathing technique (inhale for four counts, hold for seven, exhale for eight) activates the parasympathetic nervous system. Stimulus control, endorsed by both the Cleveland Clinic and NICE, instructs sufferers to leave the bed if they cannot sleep within 20 minutes, breaking the learned association between bed and anxiety.
Professor Foster’s core message is one of self-compassion: “Listening to your bodies rather than the avalanche of ‘one size fits all’ misinformation cascading down upon us” is the path to sustainable rest. The 2026 Dreams survey confirms that Britons are sleeping marginally more – 6.4 hours, up from 6.0 in 2024 – but only 5 per cent always wake feeling refreshed. Quantity has improved. Quality has not.
The Cost of Doing Nothing
The trajectory is unsustainable. If insomnia diagnoses continue to double at current rates, and if the economic cost of sleep deprivation maintains its £50 billion annual trajectory, the UK faces a public health crisis that no amount of melatonin can resolve. The World Cup, with its late-night kick-offs and disrupted routines, serves as an annual reminder of how fragile our sleep architecture really is. Professor Ashleigh Filtness, an expert in Transport Human Factors and Sleep Science at Loughborough University, warns that even short-term sleep loss during events like the tournament can have dangerous consequences for drivers: “Sleepiness is stronger than willpower and driving tired puts everyone at risk.”
The solution is not another gadget, another supplement, or another app. It is structural: expanding CBT-I access, integrating sleep health into workplace policy, training GPs to identify and manage insomnia rather than defaulting to prescriptions, and – perhaps most difficult of all – dismantling the cultural notion that sleeping less is a badge of productivity. Britain’s race thoughts are not a personal failing. They are a systemic symptom. Until the system changes, the nation will continue to lie awake, mind racing, waiting for a rest that never quite arrives.
If you are struggling with sleep, contact The Sleep Charity or speak to your GP about CBT-I referral.
